Sunil Healthcare

{
  "main_header": {
    "sid": 396654,
    "name": "Sunil Healthcare",
    "stock_name": "Sunil Healthcare",
    "full_name": "Sunil Healthcare Ltd",
    "name_url": "stocks-analysis/sunil-healthcare",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "73.00",
    "chg": -0.49,
    "chgp": "-0.67%",
    "dir": -1,
    "prev_price": "73.49",
    "mcapval": "",
    "mcap": "Micro Cap",
    "scripcode": 537253,
    "symbol": "SUNLOC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE671C01016",
    "curr_date": "Sep 21, 03:30 PM",
    "curr_time": "21:15 PM",
    "last_traded_at": "Sep 21, 03:30 PM IST",
    "bse_nse_vol": "7 ",
    "exc_status": "Active",
    "traded_date": "Sep 21, 2026",
    "traded_date_str": "2026 09 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sunil-healthcare-396654-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sunil Healthcare Ltd Upgraded to Hold on Improved Technicals and Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-upgraded-to-hold-on-improved-technicals-and-valuation-4187388",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SunilHealthcare_mojoScore_4187388.png",
        "date": "2026-09-09 08:10:57",
        "description": "Sunil Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 8 September 2026. This change reflects notable improvements in the company’s technical indicators and valuation metrics, despite flat recent financial performance. The upgrade is underpinned by a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals."
      },
      {
        "title": "Sunil Healthcare Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-by-marketsmojo-4183150",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SunilHealthcare_mojoScore_4183150.png",
        "date": "2026-09-05 10:10:29",
        "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Sunil Healthcare Ltd Valuation Improves Amid Strong Price Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sunil-healthcare-ltd-valuation-improves-amid-strong-price-performance-4175233",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunilHealthcare_valuationdot_4175233.png",
        "date": "2026-08-31 08:00:19",
        "description": "Sunil Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, signalling improved price appeal for investors within the Pharmaceuticals & Biotechnology sector. This upgrade accompanies a strong recent price performance and a positive revision in its Mojo Grade from Sell to Hold, reflecting growing market confidence despite broader sector headwinds."
      },
      {
        "title": "Sunil Healthcare Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4159034",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunilHealthcare_mojoScore_4159034.png",
        "date": "2026-08-18 08:21:15",
        "description": "Sunil Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Aug 2026. This decision follows a comprehensive reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive technical signals, the company’s weak fundamentals and flat financial performance have weighed heavily on the overall outlook."
      },
      {
        "title": "Are Sunil Healthcare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-sunil-healthcare-ltd-latest-results-good-or-bad-4152306",
        "imagepath": "",
        "date": "2026-08-13 19:44:26",
        "description": "Sunil Healthcare Ltd's latest financial results for Q4 FY26 present a complex picture. The company reported a net profit of ₹1.52 crores, which reflects a significant year-on-year increase of 322.22%. However, this profit surge was primarily driven by a one-time tax reversal of ₹2.46 crores, which artificially inflated the bottom line. When excluding this exceptional item, the company faced a pre-tax loss of ₹0.95 crores, indicating underlying operational challenges.\n\nOn the revenue front, Sunil Healthcare experienced a contraction in net sales, which amounted to ₹19.72 crores, marking a decline of 6.98% year-on-year and a more pronounced sequential drop of 9.71% from the previous quarter. This decline in revenue is particularly concerning as it represents the third consecutive quarter of decreasing sales, suggesting potential structural issues in demand rather than seasonal fluctuations.\n\nThe operating mar..."
      },
      {
        "title": "Sunil Healthcare Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-4149486",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunilHealthcare_mojoScore_4149486.png",
        "date": "2026-08-12 08:15:44",
        "description": "Sunil Healthcare Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by a marked improvement in technical indicators and attractive valuation metrics despite flat recent financial performance. The upgrade reflects a nuanced assessment across quality, valuation, financial trends, and technicals, signalling cautious optimism for investors in this micro-cap pharmaceutical player."
      },
      {
        "title": "Sunil Healthcare Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-by-marketsmojo-4132194",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SunilHealthcare_mojoScore_4132194.png",
        "date": "2026-08-02 10:10:38",
        "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Sunil Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-4112302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunilHealthcare_mojoScore_4112302.png",
        "date": "2026-07-21 10:11:16",
        "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 July 2026, providing investors with the most recent and relevant data to assess the stock’s outlook."
      },
      {
        "title": "Sunil Healthcare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sunil-healthcare-ltd-is-rated-sell-4093350",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunilHealthcare_mojoScore_4093350.png",
        "date": "2026-07-08 10:11:28",
        "description": "Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 134,
    "sid": "396654",
    "stock_news_url": "https://www.marketsmojo.com/news/sunil-healthcare-396654"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sunil Healthcare Ltd Upgraded to Hold on Improved Technicals and Valuation

2026-09-09 08:10:57

Sunil Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 8 September 2026. This change reflects notable improvements in the company’s technical indicators and valuation metrics, despite flat recent financial performance. The upgrade is underpinned by a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Sunil Healthcare Ltd is Rated Sell by MarketsMOJO

2026-09-05 10:10:29

Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Sunil Healthcare Ltd Valuation Improves Amid Strong Price Performance

2026-08-31 08:00:19

Sunil Healthcare Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, signalling improved price appeal for investors within the Pharmaceuticals & Biotechnology sector. This upgrade accompanies a strong recent price performance and a positive revision in its Mojo Grade from Sell to Hold, reflecting growing market confidence despite broader sector headwinds.

Read full news article

Sunil Healthcare Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-08-18 08:21:15

Sunil Healthcare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 17 Aug 2026. This decision follows a comprehensive reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive technical signals, the company’s weak fundamentals and flat financial performance have weighed heavily on the overall outlook.

Read full news article

Are Sunil Healthcare Ltd latest results good or bad?

2026-08-13 19:44:26

Sunil Healthcare Ltd's latest financial results for Q4 FY26 present a complex picture. The company reported a net profit of ₹1.52 crores, which reflects a significant year-on-year increase of 322.22%. However, this profit surge was primarily driven by a one-time tax reversal of ₹2.46 crores, which artificially inflated the bottom line. When excluding this exceptional item, the company faced a pre-tax loss of ₹0.95 crores, indicating underlying operational challenges. On the revenue front, Sunil Healthcare experienced a contraction in net sales, which amounted to ₹19.72 crores, marking a decline of 6.98% year-on-year and a more pronounced sequential drop of 9.71% from the previous quarter. This decline in revenue is particularly concerning as it represents the third consecutive quarter of decreasing sales, suggesting potential structural issues in demand rather than seasonal fluctuations. The operating mar...

Read full news article

Sunil Healthcare Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-08-12 08:15:44

Sunil Healthcare Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by a marked improvement in technical indicators and attractive valuation metrics despite flat recent financial performance. The upgrade reflects a nuanced assessment across quality, valuation, financial trends, and technicals, signalling cautious optimism for investors in this micro-cap pharmaceutical player.

Read full news article

Sunil Healthcare Ltd is Rated Sell by MarketsMOJO

2026-08-02 10:10:38

Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Sunil Healthcare Ltd is Rated Sell

2026-07-21 10:11:16

Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 July 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.

Read full news article

Sunil Healthcare Ltd is Rated Sell

2026-07-08 10:11:28

Sunil Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News